Welcome to the ChangeNOW Blog, where we are committed to providing accurate and trustworthy content about cryptocurrency and blockchain. Our mission is to empower readers with well-researched, unbiased information to help them make informed decisions. All content is fact-checked for accuracy, but it is for informational purposes only and does not constitute financial advice; readers should conduct their own research due to the high risks associated with cryptocurrency. We operate independently from advertisers and do not accept compensation for coverage, ensuring objective insights. We value reader feedback and encourage suggestions to improve our content while ensuring compliance with data privacy regulations.
Key Takeaways
Injective is revolutionizing DeFi as the first blockchain built for creating financial applications like exchanges, derivatives, options, and lending. It provides a super-powered platform where developers and users can seamlessly access and build DeFi products at incredible speeds, unmatched scalability, and unrivaled interoperability. Supported by top investors and enjoying a deflationary token model, Injective represents the future of financial innovation.
Key Features of Injective
- High Performance: Processes over 1.3 billion on-chain transactions since its mainnet launch, with a block time of approximately 0.65 seconds and 30,000 operations per second.
- Interoperability: Native integrations with Ethereum, Solana, Cosmos, and other ecosystems enable seamless cross-chain functionality.
- Zero Gas Fees: Scales Ethereum capabilities while eliminating gas costs for users.
- Unique Order Book Infrastructure: Supports various financial primitives like spot trading, perpetuals, options, and futures with complete MEV resistance.
- Smart Contracts: Powered by CosmWasm, enabling automated execution and DeFi applications not possible on other chains.
The Founders Behind Injective
Injective was founded by Eric Chen and Albert Chon:
- Eric Chen: A finance graduate from NYU’s Stern School and former Venture Partner at Innovating Capital.



